Journal of AIDS & Clinical Research

Pablo Tebas

Biography

He is one of the founding members of the HIV Reservoirs and Viral Eradication (Cure) Transformative Science Group (TSG) of the AIDS clinical trial group. In addition to my ACTG work, I am involved (as PI of the clinical project) in several early phase trials of new compounds developed in conjunction with the NIH in several IPCP grants, including a Phase I study evaluating the antiviral activity of aprepitant (an NK-1R antagonist that down-regulates the expression of CCR5), a phase I study evaluating the immunogenicity.

Research Interest

H1N1 (Swine flu) Virus, HIV Super Infection, HIV Vaccines Research & Development, HIV Vaccines, HIV/AIDS, Acquired Immune Deficiency Syndrome,Natural Suppliments,Natural Antibiotics,H1N1 Diagnosis

Relevant Topics